Table 4.
Analysis of GO and KEGG enrichment of Ferr-DEGs.
| Term | Description | P Value | GeneID |
|---|---|---|---|
| GO : BP | response to oxidative stress | 3.20E-13 | ALOX5/HMOX1/EGFR/NQO1/CYBB/SRC/MAP3K5/NCF2/ANGPTL7/MT3/DUSP1/GPX2 |
| GO : BP | cellular response to chemical stress | 2.59E-11 | ALOX5/HMOX1/EGFR/NQO1/CYBB/SRC/MAP3K5/NCF2/MT3/GPX2 |
| GO : BP | response to inorganic substance | 1.96E-09 | TF/HMOX1/EGFR/NQO1/CYBB/SRC/MAP3K5/MT3/MT1G/DUSP1 |
| GO : BP | cellular response to cadmium ion | 2.06E-09 | HMOX1/EGFR/CYBB/MT3/MT1G |
| GO : BP | response to ketone | 8.25E-09 | CA9/EGFR/NQO1/CYBB/SRC/AKR1C2/DUSP1 |
| GO : CC | perinuclear region of cytoplasm | 1.67E-05 | ALOX5/TF/HMOX1/EGFR/CYBB/SRC/MT3 |
| GO : CC | nadph oxidase complex | 0.000100258 | CYBB/NCF2 |
| GO : CC | endocytic vesicle | 0.000524138 | TF/EGFR/CYBB/NCF2 |
| GO : CC | secretory vesicle | 0.001115424 | ALOX5/TF/CYBB/SLC2A3/NCF2/MT3 |
| GO : CC | secretory granule | 0.003391582 | ALOX5/TF/CYBB/SLC2A3/NCF2 |
| GO : MF | hexose transmembrane transporter activity | 4.05E-06 | SLC2A3/SLC2A14/SLC2A6 |
| GO : MF | sugar transmembrane transporter activity | 6.98E-06 | SLC2A3/SLC2A14/SLC2A6 |
| GO : MF | oxidoreductase activity acting on nadph | 1.59E-05 | NQO1/CYBB/NCF2/AKR1C2 |
| GO : MF | carbohydrate transmembrane transporter activity | 2.33E-05 | SLC2A3/SLC2A14/SLC2A6 |
| GO : MF | dehydroascorbic acid transmembrane transporter activity | 4.64E-05 | SLC2A14/SLC2A6 |
| KEGG | Fluid shear stress and atherosclerosis | 0.006171 | HMOX1/NQO1/SRC/MAP3K5/NCF2/DUSP1 |
| KEGG | Ferroptosis | 1.18E-06 | TF/HMOX1/CYBB |
| KEGG | HIF-1 signaling pathway | 2.86E-07 | TF/HMOX1/EGFR/CYBB |
| KEGG | Mineral absorption | 0.001037 | TF/HMOX1/MT1G |
| KEGG | Bladder cancer | 0.042805 | EGFR/SRC |